NCT04103918View on ClinicalTrials.gov

Evaluate The Performance And Safety Of The Medical Device Jalucomplex®

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

January 20, 2021

Study Completion Date

January 20, 2021

Conditions
Wrinkle
Interventions
DEVICE

Jalucomplex

Jalucomplex is an injectable intradermal gel containing sodium salts derived from hyaluronic acid.

Trial Locations (1)

300425

SCM Dr. Rosu, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

I.R.A. Istituto Ricerche Applicate S.p.A.

NETWORK

NCT04103918 - Evaluate The Performance And Safety Of The Medical Device Jalucomplex® | Biotech Hunter | Biotech Hunter